Related Experiment Video

Updated: Mar 7, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.3K

Precision oncology: Charting a path forward to broader deployment of genomic profiling

Alison M Schram1, Michael F Berger2,3, David M Hyman1,3

  • 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.

Plos Medicine
|February 22, 2017
PubMed

Abstract:

In this Perspective, David Hyman and coauthors discuss clinical research on the application of genomic information in oncology.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K

Related Experiment Videos

Last Updated: Mar 7, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.3K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55

Articles linked to this work by shared authors, journal, and citation graph.

Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers.

medRxiv : the preprint server for health sciences·2026

Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Generalist large language models complement tailor-made predictors for tumor genomics interpretation.

bioRxiv : the preprint server for biology·2026

Treatments for human epidermal growth factor receptor 2 (HER2)-altered cancers evaluated using a tumor‑agnostic approach: A narrative review.

Cancer treatment reviews·2026

Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.

JCO precision oncology·2026

World Humanitarian Day: Why humanitarian settings need more research, not less.

PLoS medicine·2026

Avoidable mortality, clinical outcomes and determinants of premature death among adults with severe or profound intellectual disability: A population-based analysis of mortality data in England.

PLoS medicine·2026

Effectiveness of a scalable, remotely delivered stepped-care intervention for psychological distress among Polish migrant workers in the Netherlands: The RESPOND randomised controlled trial.

PLoS medicine·2026

Retrofitting fiscal policies to reduce the double burden of malnutrition in Peru: A system dynamics modelling study.

PLoS medicine·2026

Socioeconomic inequalities in functional ageing trajectories in England and Canada: A comparative longitudinal cohort study.

PLoS medicine·2026

Long-term risk of cardiovascular disease after assisted reproductive technology and infertility: A cohort study.

PLoS medicine·2026

Identification of Novel Pathogenic Variants in Familial Adenomatous Polyposis Through Whole Genome Sequencing.

Human mutation·2026

Genetic and population analyses implicate thyroid-related regulation of RNF144B in chondrocalcinosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

The Factors Affecting the Screening of New Colorectal Cancer Cases Between 2020 and 2022 in Isfahan Province.

International journal of preventive medicine·2026

Improving Cervical Cancer Screening Participation Through Human Papillomavirus Self-Sampling: A Scoping Review of Evidence in Underserved Populations.

Women's health reports (New Rochelle, N.Y.)·2026

Building a genomics-capable cancer workforce: a competency-based framework for education and training in precision oncology.

EClinicalMedicine·2026

Clonal diversity of Enterobacter cloacae complex of clinical and colonizing isolates harboring NDM-type carbapenemase genes in Cuba.

IJID regions·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us